Healthcare Global Enterprises Limited has completed the winding up of its wholly owned indirect subsidiary Healthcare Global (Tanzania) Private Limited, marking the end of its corporate presence in Tanzania. The company received formal notification of the winding up on March 26, 2026, though the effective date of closure was March 02, 2026.

Subsidiary Details and Operations

Healthcare Global (Tanzania) Private Limited was a non-operating entity incorporated in Tanzania. The subsidiary had remained inactive throughout its existence, contributing nothing to the parent company's financial performance.

Financial Impact Assessment

The closure of HCG Tanzania will have no material impact on HealthCare Global Enterprises' financial position. During the last financial year, the subsidiary made no contribution to the parent company's operations or financial metrics.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all disclosure requirements as mandated by SEBI circulars SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The winding up process did not involve any sale transactions, related party dealings, or schemes of arrangement. As a non-operational indirect subsidiary, the closure represents a routine corporate housekeeping measure rather than a strategic business decision with operational implications.

Healthcare Global Enterprises Limited has completed the dispatch of its Letter of Offer for a significant rights issue, marking a key milestone in the company's capital raising initiative. The oncology-focused healthcare provider published mandatory newspaper advertisements on March 6, 2026, confirming compliance with SEBI regulations for its upcoming rights offering.

Rights Issue Overview

The company's rights issue presents substantial details for eligible shareholders:

Key Timeline and Dates

The rights issue follows a structured timeline with specific dates for various activities:

Regulatory Compliance and Publication

Healthcare Global Enterprises fulfilled its regulatory obligations by publishing advertisements in three newspapers with wide circulation on March 6, 2026. The publications included Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavanani (Kannada daily newspaper for the regional language of Bengaluru). This publication complies with sub-regulation (1) of Regulation 84 of the SEBI ICDR Regulations.

Application Process and Requirements

The rights issue mandates the use of ASBA (Applications Supported by Blocked Amount) process for all applications. Eligible equity shareholders holding shares in physical form must provide demat account details at least two working days before the issue closing date. The company has arranged with NSDL and CDSL for crediting rights entitlements under ISIN: INE075I01017.

Document Availability and Access

The Letter of Offer dated February 24, 2026, along with application forms and rights entitlement letters, has been dispatched to eligible shareholders. Electronic copies were sent to shareholders who provided valid email addresses, while physical copies were dispatched to Indian addresses on a reasonable effort basis. The documents are accessible on the company's website, registrar's portal, and stock exchange websites.

Trading and Listing Information

Existing equity shares trade on BSE (Scrip Code: 539787) and NSE (Symbol: HCG). Rights entitlements will be tradable in dematerialized form with a market lot of one rights entitlement during the renunciation period from March 11 to March 20, 2026.